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The intracellular domain of β-dystroglycan
mediates the nucleolar stress response by
suppressing UBF transcriptional activity
Paulina Margarita Azuara-Medina1, Ariana María Sandoval-Duarte1, Sara L. Morales-Lázaro2,
Ricardo Modragón-González1, Griselda Vélez-Aguilera1, Juan de Dios Gómez-López1,
Guadalupe Elizabeth Jiménez-Gutiérrez1, Reynaldo Tiburcio-Félix1, Ivette Martínez-Vieyra3, Rocío Suárez-Sánchez4,
Gernot Längst5, Jonathan Javier Magaña4, Steve J. Winder6, Arturo Ortega 7, Rita de Cassia Ramos Perlingeiro8,
Laura A. Jacobs6 and Bulmaro Cisneros 1
Abstract
β-dystroglycan (β-DG) is a key component of multiprotein complexes in the plasma membrane and nuclear
envelope. In addition, β-DG undergoes two successive proteolytic cleavages that result in the liberation of its
intracellular domain (ICD) into the cytosol and nucleus. However, stimuli-inducing ICD cleavage and the
physiological relevance of this proteolytic fragment are largely unknown. In this study we show for the ﬁrst time
that β-DG ICD is targeted to the nucleolus where it interacts with the nuclear proteins B23 and UBF (central factor
of Pol I-mediated rRNA gene transcription) and binds to rDNA promoter regions. Interestingly DG silencing results
in reduced B23 and UBF levels and aberrant nucleolar morphology. Furthermore, β-DG ICD cleavage is induced by
different nucleolar stressors, including oxidative stress, acidosis, and UV irradiation, which implies its participation
in the response to nucleolar stress. Consistent with this idea, overexpression of β-DG elicited mislocalization and
decreased levels of UBF and suppression of rRNA expression, which in turn provoked altered ribosome proﬁling
and decreased cell growth. Collectively our data reveal that β-DG ICD acts as negative regulator of rDNA
transcription by impeding the transcriptional activity of UBF, as a part of the protective mechanism activated in
response to nucleolar stress.
Introduction
Regulated proteolysis of cell surface receptors that liber-
ates biologically active proteins/peptides from the plasma
membrane (PM) to the cytosol is a critical step in a variety
of different signaling pathways that respond to external
stimuli. γ-Secretase is an intramembranous cleaving pro-
tease complex consisting of at least four proteins: pre-
senilin-1, nicastrin, anterior pharynx-defective phenotype 1,
and presenilin enhancer 21. γ-Secretase is known to be
required for the activation of many transmembrane pro-
teins, including the amyloid precursor protein, cadherins,
Notch12, and recently, dystroglycan3,4. Dystroglycan, a key
component of the dystrophin-associated protein complex
(DAPC), is transcribed from the DAG1 gene and translated
as a single propeptide, which is proteolytically processed to
generate the extracellular subunit α-dystroglycan (α-DG)
and the transmembrane subunit β-dystroglycan (β-DG)5.
α-DG binds to different extracellular matrix proteins
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including laminin, agrin, or perlecan6, while β-DG connects
actin through various cytolinker proteins including dystro-
phin or utrophin. Thereby, dystroglycan serves as a link
between the extracellular matrix and the actin-based
cytoskeleton, acting also as an adhesion and signaling
receptor5,7.
Besides its structural role in the maintenance of mem-
brane integrity, dystroglycan localization is not static but
dynamic. Phosphorylation of β-DG at Y890 triggers its
retrograde trafﬁcking from PM to the nucleus, via the
membranous endosome-endoplasmic reticulum (ER)
network, with ezrin activation enhancing the intracellular
trafﬁcking and translocon Sec61 facilitating the exit of β-
DG from the ER membrane to be accessible for importin-
dependent nuclear import through the nuclear pore8–10.
In the nucleus, β-DG is assembled with nuclear envelope
(NE) components, including emerin, and lamins A/C and
B1, to preserve the nuclear structure/function11,12 and
where it can also indirectly regulate gene expression13.
This functional diversity of β-DG, acting as a platform for
both PM- and NE-associated processes, is further
expanded by proteolytic cleavage of the protein. β-DG is
subjected to proteolytic cleavage by MMP-2 and MMP-9
to liberate its extracellular domain14,15, while the
remaining fragment, containing the transmembrane stub
and the cytoplasmic portion is thought to be subsequently
processed by γ-secretase to deliver an intracellular
domain (ICD; 12 kDa in mass but runs aberrantly on SDS-
PAGE at ~26 kDa) into the cytosol3,4. Recent evidence
showed that β-DG ICD is targeted to the nucleus in
prostate cancer cells3,13,16 nonetheless the biological sig-
niﬁcance of such localization is largely unknown. The
nucleus is organized into distinct functional compart-
ments containing speciﬁc macromolecules that govern
nuclear processes;16 for instance, the nucleolus is a pro-
minent non-membranous nuclear organelle primarily
involved in ribosome biogenesis and cellular home-
ostasis17. Thus, identiﬁcation of the destination of β-DG
ICD within the nucleus could facilitate further elucidation
of its function.
In this study we demonstrate for the ﬁrst time that
β-DG ICD is target to the nucleolus where it plays a
negative role in the regulation of ribosomal RNA (rRNA)
transcription. We provide evidence that full-length β-DG
is proteolytically processed into β-DG ICD in response to
nucleolar stress, via the Notch signaling pathway.
Remarkably, β-DG ICD binds to the rDNA promoter to
suppress rRNA synthesis by impairing the expression,
localization, and ultimately activity of the RNA poly-
merase I (Pol I) transcription factor UBF (upstream
binding factor), which further results in the down-
regulation of rRNA expression and cell proliferation.
Thus, β-DG ICD appears to be a key contributor to the
nucleolar stress response.
Results
The γ-secretase-generated intracellular domain of β-DG is
targeted to the nucleolus
We previously observed localization of β-DG to the
nucleoli in C2C12 myoblasts11; but no role for β-DG has
been described in this nuclear organelle. As a ﬁrst step, we
analyzed whether β-DG colocalizes with proteins that
deﬁne functionally distinct compartments of the nucleo-
lus. Cells were double-stained for β-DG (C20 antibody)
along with UBF, ﬁbrillarin (markers of the ﬁbrillar center,
FC), or B23 (marker of the granular component, GC) and
further analyzed by confocal microscopy. The nucleolar
immunostaining of β-DG colocalized at certain extent
with all three nucleolar proteins analyzed, as conﬁrmed by
the line intensity scan analysis and Manders’ overlapping
coefﬁcients (Fig. 1a). The speciﬁcity of C20 antibody was
demonstrated using both DG knockout C2C12 cells and
primary ﬁbroblasts from a subject with Walker–Warburg
syndrome that do not express DAG1 gene all18. Nucleoli
were strongly staining by C20 in C2C12 wild-type cells,
while a faint nuclear staining that was excluded from
nucleoli was observed in DG knockout C2C12 cells
(Supplementary Figure 1A, left panel). Furthermore, the
immunoreactive band corresponding to β-DG (~43 kDa),
which was observed in primary ﬁbroblast lysates from a
healthy subject, was absent in Walker–Warburg syn-
drome primary ﬁbroblast lysates (Supplementary Fig-
ure 1A, right panel). Finally, pre-incubation with a
blocking peptide virtually eliminated C20 immunostain-
ing in wild-type cells (Supplementary Figure 1B). In
addition, nucleolar localization of β-DG was conﬁrmed
using another anti-β-DG antibody (G5; Supplementary
Figure 1C). The nucleolus is a highly dynamic organelle
that responds to a variety of cellular stresses with mor-
phological changes19 and redistribution of proteins
implicated in ribosome biogenesis form perinuclear caps
upon inhibition of rDNA transcription20. C2C12 cells
were therefore treated with actinomycin D (0.08 µg/ml) or
DRB (0.3 µM) to cause nucleolar stress, and the effect of
treatments on β-DG distribution was evaluated by con-
focal microscopy. The formation of nucleolar caps and
nucleolar segregation/nucleolar necklaces was found after
treatment with Act D and DRB, respectively, as shown by
immunostaining for UBF and B23 (Fig. 1b). Treatment
with the vehicle alone dimethyl sulfoxide (DMSO) pro-
duced no change in the immunostaining pattern of
nucleolar proteins. Interestingly, nucleolar labeling of β-
DG also underwent redistribution in response to Act D
and DRB but remained in colocalization partially with
UBF and barely with B23, as shown by Manders’ over-
lapping coefﬁcient analysis (Fig. 1b), suggesting that β-DG
might be involved in nucleolar organization/plasticity.
Next, we investigated whether the nucleolar localization
of β-DG is dependent on nucleic acid integrity. C2C12
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myoblasts were immunolabeled for β-DG before and after
nuclease treatment, and stained with DAPI to monitor
DNA degradation, or immunolabeled for hnRNP C1/C2
antibody (RNA-binding protein) to monitor RNA
removal. DNase digestion completely removed DAPI-
labeled DNA, while treatment with RNase caused hnRNP
C1/C2 redistribution from the nucleoplasm to the nuclear
periphery and cytoplasm, thus conﬁrming the effective-
ness of nucleases treatment. DNase treatment completely
abrogated the nucleolar distribution of β-DG, while
treatment with RNase apparently increased the intensity
of β-DG nucleolar immunostaining, compared with
untreated cells (Supplementary Figure 2A and B). These
results suggest that the nucleolar localization of β-DG is
dependent on DNA.
To demonstrate conclusively that β-DG resides in the
nucleolus, C2C12 were fractionated into total, cyto-
plasmic, nuclear, and nucleolar fractions to be further
analyzed by SDS-PAGE/WB. A prominent ~30 kDa β-DG
band was found enriched, together with ﬁbrillarin, in the
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Fig. 1 β-DG colocalizes with nucleolar proteins before and after induced nucleoli disorganization. a C2C12 cells were double immunostained
for β-DG (C20 antibodies) and B23, ﬁbrillarin (Fib), or UBF. Cells were stained with DAPI for nuclei visualization prior to being subjected to confocal
laser scanning microscopy (CLSM; scale bar= 5 µm). Colocalization of β-DG with nucleolar proteins is denoted by arrowheads in the magniﬁed
images. A line intensity scan along the white line in the merge images was carried using ROI manager Multiplot (middle graphs). Right: The Manders
overlap coefﬁcient was calculated on double labeling inmunoﬂuorescences: M1 denotes the fraction of the β-DG signal coincident with the nucleolar
proteins signal over its total intensity, and M2 denotes the fraction of the nucleolar proteins signal coincident with the β-DG signal over its total
intensity. b Cells were treated with actinomycin D (Act D) or DRB for 3 h, ﬁxed and then double immunostained for β-DG and either UBF or B23.
Nuclei were stained with DAPI before CLSM analysis (scale bar= 1 µm). Typical single Z-sections are shown and colocalization of β-DG with nucleolar
proteins after drug-induced nucleoli disruption is indicated by arrowheads in the merge images. The Manders overlap coefﬁcient was calculated for
each experimental condition as peer a
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nucleolar fraction, as revealed using three different anti-β-
DG antibodies: MANDAG (mouse mab that recognizes
total β-DG levels), pTyr890 (rabbit pAb that speciﬁcally
recognizes β-DG phosphorylated at Tyr890) (Fig. 2a), and
C20 (rabbit antibody that recognizes the total β-DG pool
Supplementary Figure 1D). Nup62 (nuclear pore protein)
and calnexin (endoplasmic reticulum protein) were
recovered in the nuclear and cytoplasmic fractions,
respectively, and the two proteins were absent from the
nucleolar fraction demonstrating that no cross-
contamination occurred during cellular fractionation.
Control experiments using both DG knockout C2C12 cells
and Walker–Warburg syndrome primary ﬁbroblasts yield
no immunoreactive bands after incubation with MANDAG
antibody (Fig. 2b and Supplementary Figure 1A, right
panel), which demonstrated the speciﬁcity of this antibody
for β-DG detection. We hypothesized that the ~30 kDa
band correspond to the ICD of β-DG generated by γ-
secretase cleavage as has been described previously3,13,16.
Compatible with this assumption, lysates from cells treated
with DAPT (γ-secretase inhibitor) resulted in a dose-
dependent decrease in β-DG ICD levels that paralleled with
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Fig. 2 β-DG ICD resides in the nucleolus. a Cells were partitioned to obtain total (T), cytoplasmic (C), nuclear (N), and nucleolar (No) fractions, prior
to SDS-PAGE/WB analysis, using speciﬁc antibodies for β-DG (Mandag) or its phosphorylated counterpart (pβ-DG). Fibrillarin (nucleolar protein),
Nup62 (nuclear membrane protein), and calnexin (reticulum endoplasmic protein) were used as cellular fraction markers. b Lysates from wild-type
and DG knockout C2C12 cells were analyzed by SDS-PAGE/WB using antibodies for β-DG (Mandag) and actin (loading control), to demonstrate β-DG
antibody speciﬁcity. c Lysates from C2C12 cells treated for 24 h with the indicated concentrations DAPT (γ-secretase inhibitor) or the vehicle alone
(DMSO) were analyzed by SDS-PAGE/WB, using antibodies for β-DG, Notch intracellular domain (NICD; positive control for DAPT action), and actin
(loading control). Representative gel from three independent experiments is shown. Right. Data correspond to the mean ± SEM from three
independent experiment, with p values indicating signiﬁcant differences (unpaired t-test)
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dose-dependent reduction of the intracellular domain of
Notch (NICD), a well-characterized γ-secretase substrate
(Fig. 2c). Collectively these data support the idea that the
γ-secretase-derived cleavage fragment of β-DG (~30 kDa),
named hereafter as β-DG ICD, is targeted to the nucleolus
where it possibly has a role in regulating nucleoli structure/
function.
β-DG ICD interacts with UBF and B23
Colocalization of β-DG with nucleolar proteins even
after induced nucleolar disruption (Fig. 1b), suggests their
physical interaction. Consistent with this notion, UBF and
traces of B23 but not ﬁbrillarin were recovered in complex
with β-DG after immunoprecipitation (IP) of C2C12
lysates with anti-β-DG antibody (Fig. 3a). None of the
nucleolar proteins were immunoprecipitated using non-
speciﬁc IgG antibodies. Because anti-β-DG antibody
immunoprecipitated both β-DG full-length and β-DG
ICD, we wondered what form is bound to nucleolar
proteins. To approach this, C2C12 cells were transiently
transfected to express GFP-β-DG full-length or GFP-β-
DG ICD and subjected to GFP-based IP assays. Both UBF
and B23 were found preferentially bound to GFP-β-DG
ICD, with UBF interaction predominant over that with
B23 (Fig. 3b). GFP alone interacted with neither B23 nor
UBF, while lamin B1 (β-DG nuclear partner) was bound
to GFP-β-DG full-length but not GFP-β-DG ICD,
demonstrating the speciﬁcity of GFP-Trap assays.
Silencing of DG disrupts nucleolar morphology and
decreases B23 and UBF levels
To elucidate whether nucleolar localization of β-DG is
physiologically relevant, the impact of knocking down of
β-DG expression on nucleolar structure and expression of
nucleolar proteins was examined. Signiﬁcant reduction of
dystroglycan mRNA levels and the consequent decrease
in β-DG full-length and β-DG ICD levels were observed
upon stably transfection of C2C12 cells with a vector
expressing a short hairpin RNA against DAG1 gene (DG
shRNA), compared to cells expressing an unspeciﬁc
shRNA (control shRNA) (Fig. 4a, b). Remarkably, the
depletion of β-DG resulted in decreased proteins levels of
B23 (80%), ﬁbrillarin (30%), and UBF (60%) (Fig. 4b). Such
effects were accompanied by a clear alteration in
nucleolar morphology; while control shRNA cells contain
numerous relatively small nucleoli, β-DG-depleted cells
exhibited fewer larger and more amorphous nucleoli, as
shown by immunostaining for UBF and B23 (Fig. 4c, d)
and quantiﬁcation of nucleolar area (right panels).
β-DG binds to the rDNA promoter to possibly regulate
rRNA expression
Because knockdown of β-DG resulted in decreased
levels of UBF, a key component of the RNA polymerase I
preinitiation complex in rRNA transcription, we sought to
determine the expression of 28 S and 18 S pre-rRNAs in
β-DG knockdown cells by quantitative RT-PCR (Fig-
ure 4a). β-DG knockdown cells exhibited an ~40%
decrease in 18 S levels, while 28 S expression showed a
slight but signiﬁcant increase, compared with control
shRNA (Fig. 5a). To provide insight into the mechanism
by which β-DG depletion inﬂuences rDNA gene expres-
sion, we analyzed whether β-DG is physically associated
with the rDNA promoter. Chromatin was immunopreci-
pitated from wild-type and DG knockout (negative con-
trol) C2C12 cells, using β-DG or nonspeciﬁc IgG
B23
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IgG0 IP IgG0 IP
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Fig. 3 β-DG ICD interacts with the nucleolar proteins UBF and
B23. a C2C12 cell lysates were subjected to immunoprecipitation (IP)
using anti-β-DG antibody (Mandag) and the precipitated proteins
were subsequently analyzed by western blotting using primary
antibodies against β-DG, UBF, B23, or ﬁbrillarin. b Lysates from cells
transiently expressing GFP-β-DG full-length, β-DG ICD, or GFP alone
were subjected to immunoprecipitation using the GFP-Trap system,
and the captured proteins were analyzed by western blotting using
antibodies against B23, UBF, lamin B1 (LB1), and GFP. a, b Ub,
unbound proteins, IP immunoprecipitated fraction, IgG0, nonspeciﬁc
antibody. Input corresponds to 10% of protein lysates prior to
immunoprecipitation
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antibodies; moreover, ChIP assays using RNA polymerase
I (Pol I) antibodies were performed in parallel (positive
control). Then, rDNA was ampliﬁed using primers
speciﬁc for the rDNA promoter, 5.8 S or intergenic spacer
(IGS) regions. ChIP assays revealed the presence of β-DG
in the 5.8 S and IGS regions, while Pol I was found to
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Fig. 4 Silencing of dystroglycan results in altered nucleoli structure and reduced levels of B23 and UBF. a Messenger RNA expression of
dystroglycan and GAPDH (endogenous control) was assessed by qRT-PCR in C2C12 cells stably expressing DG shRNA or control shRNA, as described
in Methods. Relative mRNA levels obtained in control cells were set at 1. Results are the mean ± standard deviation of three independent
experiments, with P value indicating signiﬁcance difference (unpaired t-test). b Lysates from C2C12 cells stably transfected with DG shRNA or control
shRNA were analyzed by western blotting using primary antibodies against DG, B23, ﬁbrillarin, UBF, and calnexin (loading control). Blots were stripped
and reprobed successively with each protein antibody. Relative protein levels from control shRNA cells were set at 1 for comparison. Results are the
mean ± SEM of three independent experiments (right panel), with p value denoting signiﬁcance differences (unpaired t-test). c, d Nucleolar
morphology was analyzed in cells stably expressing DG shRNA or control shRNA, using speciﬁc antibodies against UBF and B23 respectively. Cells
were counterstained with DAPI to visualize nuclei prior to CLSM analysis. The nucleolar area (μm2) was determined in each cell condition as described
in Methods (graphs at right). Data are the mean ± SEM from three independent experiments (n= 600 nucleoli), with p values indicating signiﬁcant
differences (unpaired t-test)
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occupy all three regions of the rDNA (Fig. 5b). As
expected, no PCR ampliﬁcation was detected upon ChIP
assays on DG knockout cells (right panel), which
demonstrated the speciﬁcity of Mandag antibody for
immunoprecipitating β-DG from chromatin. Overall
these data suggest that β-DG may modulate rRNA
transcript expression through its binding to the rDNA
regulatory region.
Nucleolar stress-induced β-DG ICD cleavage correlates
with impaired ribosome biogenesis
In an effort to understand the potential role of β-DG
ICD in the nucleolus, we investigated whether β-DG ICD
cleavage is induced by nucleolar stress. C2C12 cells were
subjected to different kind of stresses, namely oxidative
stress, acidosis, and UV irradiation, and effectiveness of
treatments was monitored by p53 activation. Interestingly,
the ratio of β-DG ICD/full-length β-DG was augmented
in response to all treatments with concomitant decrease
in UBF content, with H2O2 and UV being the most efﬁ-
cient inductors (Fig. 6a, b). As expected, H2O2-induced
nucleolar stress resulted in nucleolar segregations, with a
formation of UBF-stained nucleolar caps at the periphery
of B23-stained nucleoli (Supplementary Figure 3), which
elicited ultimately downregulation of 45 S rRNA expres-
sion (Fig. 6c) and abnormal ribosomal proﬁling char-
acterized by decreased monosomes and polysome
absorbance peaks (Fig. 6d). We hypothesized that aug-
mented β-DG ICD levels could be reﬂected in a higher
binding activity to the rDNA promoter; consistent with
this idea, occupancy of the three rDNA regulatory regions
by β-DG markedly increased after H2O2 treatment, as
revealed by ChIP-qPCR assays (Fig. 6e).
Overexpression of β-DG ICD impairs ribosomal biogenesis
by suppressing UBF function
To analyze directly the implication of β-DG ICD in
ribosome biogenesis, we stably transfected C2C12 cells
with a GFP-β-DG ICD vector, to mimic high levels of the
cleavage fragment. GFP-β-DG ICD localization was
restricted to the nucleus showing homogenous distribu-
tion throughout the nucleoplasm, with less intense
staining in nucleoli (Fig. 7a). Remarkably, the signiﬁcant
number of GFP-β-DG ICD-transfected cells exhibited
mislocalization of UBF foci to the cytoplasm, compared to
GFP alone (50% and 20%, respectively), while the
nucleolar distribution of B23 remained unaltered (Fig. 7a,
bottom panel and right panel). Impaired nucleolar loca-
lization of UBF due to exogenous β-DG ICD expression
was conﬁrmed by transfecting FLAG-tagged β-DG ICD
(Supplementary Figure 4, top rows). Furthermore, over-
expression of GFP-β-DG ICD resulted in decreased levels
of UBF with no effect on B23, compared to GFP alone
(Fig. 7b and right panel). We have demonstrated pre-
viously that the phosphorylation of β-DG at Tyr890 is not
only a signal for the proteolysis and internalization of
dystroglycan3,16,22 but also acts to target dystroglycan to
the nucleus10. We considered therefore whether phos-
phorylation of β-DG ICD at the PPxY motif (Tyr890) plays
a role in UBF mislocalization. Thus, FLAG-β-DG ICD
A)
B)
Promoter 18S 5.8S 28S
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IGS region
5.8S region
Promoter
100  
200  
100  
100 
bp
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Fig. 5 β-DG binds to the rDNA gene regulatory region and
knockdown of DG expression alters rRNA expression. a Total RNA
was isolated from control shRNA and DG shRNA stably transfected
cells and the expression of 18 S and 28 S pre-rRNAs was assessed by
qRT-PCR using GAPDH as endogenous control. The expression levels
obtained in control shRNA cells were set at 1 for comparison. Data
correspond to the mean ± SEM from three independent experiments
with duplicates; p values denoted signiﬁcant differences (unpaired t-
test). b Wild-type and DG knockout C2C12 cells were subjected to
chromatin immunoprecipitation (ChIP) with antibody anti-β-DG
(MANDAG), followed by PCR assays for the promoter, 5.8 S and IGS
(intergenic sequence) regions of rDNA gene. ChIP assays using anti-
PolI antibody were carried out in wildtype C2C12 cells as positive
control. The drawing at the top shows the organization of the rDNA
gene (bottom panel). IgG0 nonspeciﬁc antibodies, (-) mock reaction
without antibodies
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variants that either mimic (Y890E) or block (Y890A) the
Tyr890 phosphorylation were analyzed for UBF localiza-
tion. Similar percentage of transfected cells showing UBF
outside of the nucleus were observed between β-DG ICD
FLAGY890A and β-DG ICD-FLAGY890E; thus, over-
expression of β -DG ICD resulted in UBF mislocalization
irrespective of a charged residue at residue 890 that
mimics phosphorylation (Supplementary Figure 4). We
hypothesized that decreased expression/mislocalization of
UBF through β-DG ICD overexpression would ultimately
impact rRNA expression. Consistent with this idea, an
~50% decrease in 45 S rRNA and 28 S but not 18 S was
found in cells stably overexpressing β-DG ICD, compared
with those expressing GFP alone (Fig. 8a). To ascertain
whether β-DG ICD overexpression inﬂuences Pol I tran-
scription, functional rRNA promoter reporter assays were
carried out in β-DG ICD stably transfected cells, using a
vector that expresses Fireﬂy luciferase under the control
of the mouse rRNA promoter and a vector that expresses
Renilla luciferase to normalize transfection efﬁciency. Pol
I promoter activity was found to decrease by 40% in GFP-
β-DG ICD-transfected, compared with those with GFP
alone (Fig. 8b). Because the rRNA content is a crucial
point of regulation for ribosome biogenesis, we hypothe-
sized that decreased 40 S and 60 S levels would impact the
ribosome proﬁle. Consistent with this notion, altered
ribosome proﬁles devoid of the peaks corresponding to
free 40 S and 60 S ribosomal subunits were observed in
cells expressing β-DG ICD (Fig. 8c). Such impairment in
rRNA expression and polysome proﬁling ultimately leads
to defective proliferative capacity of β-DG ICD over-
expressing cells, as shown by MTT-based proliferation
assays (Fig. 8d). Collectively these data indicate that β-DG
ICD acts as negative regulator of rRNA expression by
affecting both the levels and transcriptional activity of
UBF.
Discussion
β-DG is a key component of both PM and NE, acting as
a platform for the proper anchorage of organelle-speciﬁc
protein assemblies. At the PM β-DG modulates adhesion/
signaling by connecting extracellular matrix proteins with
the actin-based cytoskeleton5,7, while in the nucleus β-DG
interacts with the NE proteins emerin and lamins A/C
and B1 to regulate nuclear structure and function11,12.
This functional diversity could be wider than originally
thought, due to the potential function of β-DG proteolytic
fragments. Recent in vitro and in vivo evidence showed
that β-DG undergoes two successive and possibly coor-
dinate proteolytic cleavages that result in the liberation of
the intracellular domain (ICD) into the cytosol; ﬁrst
matrix metalloproteinases, MMP-2 and MMP-9 cleave
the extracellular domain of β-DG23 and create a
membrane-tethered intermediate that is subsequently
processed by γ-secretase, a PM-embedded protease
complex, to render a ﬁnal cleavage product that approx-
imates the entire ICD21. Except for cell density21, other
cellular stimuli inducing β-DG ICD release as well as the
physiological consequences of such processing event are
largely unknown. In this study we showed that β-DG ICD
associates to nucleoli and its cleavage is promoted by the
induction of a different kind of nucleolar stresses. We also
ascribed for the ﬁrst time a role for β-DG ICD in reg-
ulating rRNA transcription through negative regulation of
the expression and transcriptional activity of UBF, in the
context of the response to nucleolar stress.
We show herein that β-DG colocalizes and interacts
with the key nucleolar proteins B23 and UBF, and, based
on the converging redistribution of β-DG with B23,
ﬁbrillarin, or UBF in response to both actinomycin- and
DRB-induced nucleoli disorganization, we hypothesized
that β-DG participates in the functional plasticity of
nucleoli. Interestingly, cell fractionation experiments
revealed the presence of β-DG ICD but not β-DG full-
length in the nucleolar fraction of C2C12 cells; however,
GFP-based IP experiments revealed that both β-DG ICD
and β-DG full-length are able to bind UBF. Because full-
length β-DG is an NE protein associated with nuclear
lamin and because the interaction of intranuclear ﬁla-
ments of lamins with nuclear compartments (including
nucleoli) has been well established24–26 it is possibly that
IP of β-DG full-length pulled down a nuclear
(see ﬁgure on previous page)
Fig. 6 Nucleolar stress triggers β-DG ICD and disturbs rRNA expression and ribosome proﬁle. a Lysates from control (ctrl, untreated) cells or
cells induced to nucleolar stress response by H2O2 treatment, UV irradiation or acidosis (pH 6) (see Methods for details) were analyzed by western
blotting using speciﬁc antibodies against β-DG, UBF, B23, p53, and α-tubulin. b Quantiﬁcation of β-DG ICD/β-DG full-length ratio and UBF levels was
carried out using α-tubulin as loading control. Results correspond to the mean ± SEM of three independent experiments with p values denoting
signiﬁcant differences (ordinary one-way ANOVA). c The 45 S rRNA precursor expression was assessed by qRT-PCR using GAPDH as endogenous
control. The expression levels obtained in control cells were set at 1 for comparison. Data correspond to the mean ± SEM from three independent
experiments with duplicates; p values denoted signiﬁcant differences (unpaired t-test). d Ribosome proﬁling from control and H2O2-treated cells are
shown. e Chromatin immunoprecipitation assays on control and H2O2-treated C2C12 cells were performed, with speciﬁc antibody against β-DG
(Mandag), followed by SYBR green-based qPCR assays for the promoter, 5.8 S and IGS (intergenic sequence) regions of rDNA gene. Scheme of rDNA
gene regulatory regions is shown at the top
Azuara-Medina et al. Cell Death and Disease          (2019) 10:196 Page 9 of 17   196 
Ofﬁcial journal of the Cell Death Differentiation Association
macromolecular complex containing NE (lamin B1) and
nucleolar (UBF) proteins. The trafﬁcking pathway
underlying nucleolar targeting of β-DG ICD remains to
be deciphered. Full-length β-DG is translocated to the
nucleus through recognition of its NLS by importins
α2/β19, therefore it is likely that β-DG ICD enters the
nucleus by virtue of the NLS that is still present in the
cleaved fragment, or alternatively by passive diffusion
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Fig. 7 Overexpression of β-DG ICD induces mislocalization and reduces UBF levels. a C2C12 cells transiently expressing GFP or GFG-β-DG ICD
were immunolabeling for UBF at 24 h post-transfection. Cells were then ﬁxed, stained with phalloidin and DAPI to visualize actin and nuclei,
respectively, and subjected to CLSM analysis. In parallel experiments transfected cells were double immunostained for UBF and B23 and
counterstained with DAPI to visualize nuclei prior to CLSM analysis (bottom panels). Scale bar= 10 µm. Mislocalized UBF is denoted by arrowheads.
Quantiﬁcation of cells transfected with GFP and GFP-β-DG ICD that showed UBF outside of the nucleus (right panel). Results correspond to the mean
± SEM of three independent experiments with p values denoting signiﬁcant differences (unpaired t-test), n= 50 per experiment. b Lysates from GFP-
or GFG-β-DG-ICD-transfected cells were analyzed by western blotting using speciﬁc antibodies against GFP, UBF, B23, and actin (loading control).
Right: Data correspond to the mean ± SEM from three independent experiments, with p values indicating signiﬁcant differences (unpaired t-test)
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through the nuclear pore complex (NPC), because its
molecular mass (<30 kDa) is clearly below the NPC per-
missive size27. No obvious nucleolar localization signal is
found in β-DG ICD, thus, its nucleolar accumulation
might be mediated by a retention mechanism via inter-
action with nucleolar components. Supporting this idea,
β-DG ICD was found to interact with B23, a shuttle
protein that transports cargos between the cytoplasm and
the nucleolus and mediates nucleolar retention of other
proteins28. Furthermore, binding of β-DG to the rDNA
gene regulatory region (see below) could serve to anchor
β-DG ICD to nucleoli too. Owing to the main
contribution of nucleoli in ribosome biogenesis16, we
wondered whether β-DG is involved in this process. We
provide here solid evidence supporting this hypothesis:
ﬁrst, β-DG interacts with UBF, an HMG box-containing
protein that binds directly with rDNA and plays an
important role in the recruitment of SL1 (selectivity factor
1) and Pol I to the rRNA promoter to constitute the Pol I
preinitiation machinery complex29; second, ChIP assays
with anti-β-DG antibody demonstrated β-DG recruitment
to the rDNA 5.8 S and IGS regulatory regions; and third,
DG silencing resulted in reduced UBF levels, decreased
18 S pre-rRNA expression but not 28 S pre-rRNA
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Fig. 8 Exogenous expression of β-DG ICD impairs ribosome biogenesis by affecting transcriptional activity of UBF. C2C12 cells were
transfected to stably express GFP-β-DG ICD or GFP alone (empty vector). a The expression of 45 S, 18 S, and 28 S rRNAs was analyzed in the
transfected cell cultures, using GAPDH as endogenous control. b Schematic representation of the mouse rDNA promoter construct (pMrTsp-9-T10)
and Renilla luciferase control vector is shown at the top. Cell cultures stably expressing GFP-β-DG ICD or GFP alone were co-transfected with both
luciferase reporter constructs and transcriptional activities were estimated after incubation for 48 h, as described in Methods. Control condition
obtained in cells transfected with GFP alone was set at 1 for comparison. Data represent mean ± SEM of three independent experiments; p values
denote a signiﬁcant difference (unpaired t-test). c The ribosomal gradient proﬁles obtained from transfected cell cultures are shown. d Cell
proliferation of the stably transfected cell cultures was monitored over a 10-day period using the MTT assay. Data represent mean ± SEM of three
independent experiments
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Fig. 9 Schematic model showing the effect of β-DG ICD on rRNA synthesis in response to nucleolar stress. a Under normal conditions, β-DG
ICD locates in nucleoli through its interaction with UBF, although additional proteins might be involved as well. b The nucleolar stress response
triggers ɤ-secretase-mediated β-DG ICD cleavage and its further accumulation in the nucleolus. Increased β-DG ICD content inhibits rRNA synthesis
by affecting both the localization and protein levels of UBF
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expression, and aberrant nucleolar morphology. Dis-
cordant expression between 28 S and 18 S rRNAs is
intriguingly. Even though both 28 S rRNA and 18 S rRNA
are originated from 45 S rRNA precursor, their proces-
sing/maturation pathways differ from each other, and each
one is assisted by speciﬁc exo and endoribonucleasas30.
Therefore, we argue that aside from its effect on rDNA
basal transcription machinery (as shown here), β-DG ICD
might modulate processing pathways of 18 S rRNA and
28 S rRNA differentially by indirect mechanisms. Addi-
tional experiments are needed to clear this issue.
The nucleolus is a central hub for orchestrating stress
response, with downregulation of rRNA synthesis taking
place as a part of ribosome biogenesis surveillance31,
furthermore, numerous proteins that functions are not
generally ascribed to ribosome biogenesis are recruited to
the nucleolus in response to environmental stimuli32.
Therefore, we ascertained whether β-DG ICD cleavage is
coupled to the response to nucleolar stress. Remarkably,
triggers of β-DG ICD cleavage by Notch signaling acti-
vation occurred in response to different nucleolar stressor
treatments, including oxidative stress, acidosis, and UV
irradiation. Supporting a role for β-DG ICD in the
response to nucleolar stress, β-DG ICD overexpression
was sufﬁcient to elicit several features of nucleolar stress,
including mislocalization and decreased levels of UBF,
repression of rRNA transcription, altered ribosome pro-
ﬁle, and decreased cell proliferation.
The results raise the question of how β-DG ICD exerts a
negative regulation on rDNA expression. β-DG lacks
DNA-binding motifs or enzymatic activity and is con-
sidered as a scaffold protein, due to the presence of pro-
tein modules supporting interactions with diverse
proteins (e.g. SH3, SH2, and WW domains)5. Therefore,
we postulate that binding of β-DG ICD to UBF may lead
to mislocalization and decreased levels of the latter pro-
tein, possibly by altering its stability, thereby interfering
with the assembly of the Pol I initiation complex and the
subsequent UBF-dependent activation of rDNA tran-
scription (Fig. 9). Because the occupancy of rDNA reg-
ulatory regions by β-DG increased in response to
nucleolar stress, it is also possible that β-DG ICD exerts
its suppressive effect by displacing UBF from the Pol I
transcription complex, which is consistent with mis-
localization of UBF to the nucleolar periphery and cyto-
plasm that was observed in H202-treated cells. Further
ChIP assays to ascertain whether β-DG and UBF coexist
or not in the rDNA promoter region under nucleolar
stress conditions are needed to solve this question. Fur-
thermore, since β-DG has multiple partners in the
nucleus, the existence of an indirect mechanism by which
β-DG ICD represses UBF activity cannot be ruled out.
The implication of β-DG ICD in rDNA expression could
be envisioned as an extension of the homeostatic role of
β-DG, where induction of ICD cleavage and its further
targeting to the nucleolus in response to environmental
stress, like oxidative stress, acts as a protective response to
inhibit rDNA transcription and further proliferation of
damaged cells.
In summary, our data are compatible with the paradigm
that β-DG ICD functions as a negative regulator of rRNA
transcription by impeding the transcriptional activity of
UBF, as a part of the nucleolar stress response mechan-
isms that are activated under physiologically relevant
stress conditions. Thus, in addition to its roles as PM and
NE signaling scaffold, β-DG should be regarded as a
regulator of Pol I transcription in the nucleolus.
Materials and methods
Cell culturing and treatments
Mouse C2C12 myoblasts (ATCC® CRL-1772™) were
grown as previously (Vásquez-Limeta, et al 2014).
Generation of C2C12-derivative DG knockout cell lines
with the CRISP/Cas9 system will be published else-
where. For nucleoli disorganization treatments, cells
were treated for 3 h with 0.01 μg/ml Act D (Sigma-
Aldrich, St Louis, Missouri) or 25 µg/ml DRB (5,6
dichloro-1–d-ribofuranosylbenzimidazole; Sigma-
Aldrich, St Louis, Missouri) or vehicle alone (DMSO),
prior to confocal laser scanning microscopy (CLSM)
analysis. The ɤ-secretase inhibitor N-(N-(3,5-diﬂuor-
ophenacetyl)-L-alanyl). S-phenylglycine t-butyl ester
(DAPT; Sigma-Aldrich, St Louis, Missouri) was used at
10 µM for 24 h. For induction of the nucleolar stresses
response, cells were cultured in DMEM supplemented
with serum adjusted to pH 6, treated with 1.4 mM H2O2
(7722-84-1,Sigma-Aldrich) for 4 h or subjected to UV
radiation using a pulse of 20 J/cm2 each 24 h for 2 days.
For nuclease digestion assays, cells grown on coverslips
were treated with either 100 μg/ml protease-free RNase
A in CSK buffer (10 mM Pipes pH 6.8, 100 mM NaCl,
30 mM sucrose, 3 mM MgCl2, 1 mM EGTA, 0.5% (v/v)
Triton X-100) for 40 min at 37 °C or with 200 μg/ml
protease-free DNase I in PBS with 5 mM MgCl2 for 1 h
at 37 °C, then the cells were ﬁxed with PFA 4% and
immunolabeled using primary antibodies and the cor-
responding ﬂuorochrome-conjugated secondary anti-
bodies. Negative control experiments were carried out
by incubating cells only with CSK buffer (RNase) or PBS
with 5 mM MgCl2 (DNase) prior to ﬁxation.
Plasmids and transfection
The expression vectors Flag-β-DG ICD WT, Flag-β-DG
ICDY890E, and Flag-β-DG ICDY890A were generated by
PCR ampliﬁcation using DGWT-DG, DGY890E-GFP,
and DGY890A-GFP plasmids as template, respectively10.
The cDNA sequence encoding the intracellular domain of
β-DG (ICD, amino acids 774–895) was ampliﬁed using an
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M-MLV reverse transcriptase coupled to a high-ﬁdelity
polymerase (Pfu turbo; Strategene) and primers contain-
ing Hind III and EcoRI restriction sites. Forward primer
was 5′-CCTAAGCTTTATCGCAAGAAGAGGAAGGG
C-3′ and the respective reverse primers were 5′-CTGAAT
TCTTAAGGGGGAACATACGGAGGG-3′ (ICD WT),
5′-CTGGAATCCTTAAGGGGGAACCTCCGGAGGG-
3′ (ICD Y890E mutation), and 5′-CTGAATTCTTAAG
GGGGAACTGCCGGAGGG-3′ (ICD Y890A mutation).
PCR products were double digested with Hind III and
EcoRI and cloned into the Hind III-EcoRI digested pFlag-
CMV-10 vector. The integrity of the constructs was
conﬁrmed by DNA sequencing. Transfection was per-
formed following supplier’s recommendations. Brieﬂy,
cells seeded onto glass coverslips were incubated over-
night and then transfected with 3 μg of the corresponding
vector premixed with 3 μl of Lipofectamine 2000 (Invi-
trogen, Carlsbad, CA, USA). Transiently transfected cells
were analyzed at 24 h post-transfection. When indicated,
cells were stably transfected by culturing them for 12 days
in the presence of 2 µg/ml puromycin (Invitrogen) or for
5 days in the presence of 800 µg/ml gentamicin (G418),
prior to being used for further experiments. For knock-
down experiments, cells were stably transfected with psi-
mH1 vector expressing a small interfering RNA (RNAi)
speciﬁc for mouse DAG1 gene or a scrambled RNAi, as
negative control (GeneCopoeia, Inc., Rockville, MD). For
overexpression analysis, cells were stably transfected with
GFP constructions as previously reported9.
Antibodies
The following anti-β-DG primary antibodies were used:
rabbit polyclonal antibodies G5 (Royuela et al, 2001) and
Dystroglycan pTyr892 (Ilsley et al, 2002); goat polyclonal
antibody C20 (Santa Cruz Biotechnology, CA), and mouse
monoclonal antibodies MANDAG233 and 7D11 (Santa
Cruz). Rabbit polyclonal antibodies anti-B23 (C19-R),
anti-Nup62 (H-122), anti-calnexin (H70), anti-ﬁbrillarin
(Ab5821), anti-GFP (sc8334) and mouse monoclonal
antibodies anti-UBF (F9), anti-B23 (NPM1-FC-61991)
(anti-RNA polymerase I (sc-46699), anti-lamin B1
(Ab16048), anti-and anti-RPA(sc-46699), and α-Tubulin
(sc-32293) were purchased from Santa Cruz Biotechnol-
ogy, CA, USA. Rabbit polyclonal anti-Flag (2368) and
rabbit monoclonal anti-Notch1 (4147) antibodies were
acquired from cell signaling, while mouse monoclonal
anti-actin antibody was a gift from Dr. Manuel Hernández
(CINVESTAV, Mexico City).
Immunoﬂuorescence and confocal microscopy analysis
Cells grown on coverslips were ﬁxed with 4% paraf-
ormaldehyde for 10min in PBS, permeabilized with 0.2%
Triton X-100-PBS, blocked with 0.5% fetal bovine serum
and 3% bovine serum albumin (BSA) in PBS and incubated
overnight at 4 °C with the appropriate primary antibodies.
The following day, cells were washed with 0.2% Triton X-
100-PBS for 5min and then with PBS alone three times,
prior to be incubated for 1 h at room temperature with the
appropriate ﬂuorochrome-conjugated secondary antibody.
For double immunolabeled samples, this was followed by
overnight incubation at 4 °C with corresponding primary
antibodies and the next day, cells were incubated with
secondary ﬂuorochrome-conjugated antibodies. Where
indicated F-actin was labeled using TRITC-conjugated
Phalloidin (Sigma-Aldrich St. Louis, Mo. USA) diluted
1:500 in PBS for 10min at room temperature. For nuclease
digestion assays, cells grown on coverslips were treated with
either 100 μg/ml protease-free RNase A in CSK buffer (10
mM Pipes pH 6.8, 100mM NaCl, 30mM sucrose, 3mM
MgCl2, 1 mM EGTA, 0.5% (v/v) Triton X-100) for 40min at
37 °C or with 200 μg/ml protease-free DNase I in PBS with
5mM MgCl2 for 1 h at 37 °C. Cells were then immunola-
beled using primary antibodies and the corresponding
ﬂuorochrome-conjugated secondary antibodies. Finally,
coverslip preparations were incubated for 20min at room
temperature with 0.2 µg/ml diamidino-2-phenylindole
(DAPI; Sigma-Aldrich) for nuclei visualization, mounted
on microscope slides with VectaShield (Vector Laboratories
Inc. Burlingame, CA, USA) and further analyzed by CLSM
(TCP-SP5, Leica Microsystems, Heidelberg, Germany)
using a Plan Neo Fluor 63 × (NA= 1.4) oil-immersion
objective. Analyses of digitized images were carried out
using ImageJ 1.62 software. The nucleolar area (μm2) of 600
nucleoli was analyzed in maxima projection using 3D
objects counter and the data were analyzed using
Prism6 software. Manders overlap coefﬁcients were calcu-
lated for double labeling inmunoﬂuorescences, using red
(Alexa 594 nm) and green (FITC 488 nm) channels and the
ImageJ plugin JACoB. A line intensity scan analysis was
performed by ROI manager Multiplot.
Western blotting
Cell lysates were electrophoresed on 10% SDS-
polyacrylamide gels and transferred onto nitrocellulose
membranes (Hybond-Nb, Amersham Pharmacia, GE
Healthcare, Bukinghamshire, UK). Membranes were
blocked in TBST (100mM Tris-HCl pH 8.0, 150mM
NaCl, 0.5 % (v/v) Tween-20) with low fat-dried milk and
then incubated overnight at 4 °C with the appropriate
primary antibodies. The speciﬁc protein signal was
developed using the corresponding secondary antibodies
and enhanced chemiluminescence western blotting
detection system (ECLTM; Amersham Pharmacia, GE
Healthcare), according to the manufacturer's instructions.
Cell fractionation
Total cell extracts were obtained with lysis Buffer (10
mM Tris-HCl pH 8, 30 mM NaCl, 0.2% Triton X-100, 4
Azuara-Medina et al. Cell Death and Disease          (2019) 10:196 Page 14 of 17   196 
Ofﬁcial journal of the Cell Death Differentiation Association
mM Na3O4V, 50 mM NaF, 20 mM Na2MoO4, 1 mM
PMSF, 1X complete protease inhibitor) sonicated three
times at 3.5 μm with 15 s bursts and analyzed by western
blotting. Puriﬁcation of the cytosolic, nuclear, and
nucleolar fractions was performed as previously repor-
ted34. A total amount of ﬁfteen 100 mm dishes grown to
90% conﬂuence were used; cells were washed twice with 1
ml of ice-cold PBS and collected by centrifugation at
15,000 rpm for 15min at 4 °C. The pellet was resuspended
in 1ml of buffer TM (10mM Tris-HCl pH 8, 2 mM
MgCl2, 25 mM NaF, 10 mM Na2MoO4, 2 mM Na3VO4, 1
mM PMSF), supplemented with 1× complete protease
inhibitor mixture (Roche Applied Science, Indianapolis,
USA), and incubated on ice for 10 min. Then, 2% Triton
X-100-PBS was added, and the homogenate incubated for
10min on ice, transferred to a glass Dounce homogenizer,
stroked 30 times with B pestle, and centrifuged at 5,000
rpm for 15 min at 4 °C. The supernatant was recovered as
the cytosolic fraction and the nuclear pellet was resus-
pended in 1ml of buffer I (0.32M Sucrose, 3 mM CaCl2,
2 mM Mg(CH3COO)2, 0.1 mM EDTA, 10mM Tris-HCl
pH 8, 1 mM DTT, 0.5 mM PMSF, 0.5% (v/v) NP40) and 1
ml of Sucrose buffer II (2M Sucrose, 5 mM Mg
(CH3COO)2, 0.1 mM EDTA, 10mM Tris-HCl pH 8.0, 1
mM DTT, 0.5 mM PMSF), and further puriﬁed by sucrose
gradient centrifugation at 16,000 rpm for 1 h at 4 °C. The
pellet was resuspended in 600 µl of buffer III (0.34M
Sucrose, 1 mM MgCl2, 0.1 mM EDTA, 10 mM Tris-HCl
pH 8.0, 1 mM DTT, 0.5 mM PMSF) and aliquots collected
for extraction of nuclear and nucleolar proteins. For
nuclear proteins, the aliquot was centrifuged at 1,000 rpm
for 5 min at 4 °C and the pellet resuspended in 200 µl of
lysis buffer (50 mM Tris-HCl pH 8.0, 150mM NaCl, 1
mM PMSF, 1% (v/v) Triton X-100), supplemented with
protease inhibitor cocktail and phosphatase inhibitors,
sonicated 3 times at 4μm with 15 s bursts and 4min on ice
between intervals, and then pre-cleared at 13,000 rpm for
2 min at 4 °C. For puriﬁcation of nucleoli, the remaining
350 µl aliquot was sonicated 5 times at 5 μm with 30 s
bursts and analyzed under a light microscope to ensure
nucleoli integrity, prior to puriﬁcation by centrifugation at
3,000 g for 20 min at 4 °C through a sucrose gradient,
using buffer III and four volumes of Sucrose buffer IV
(0.88M Sucrose, 0.1 mM EDTA, 10mM Tris-HCl pH 8.0,
1 mM DTT, 0.5 mM PMSF). Finally, the pellet was
washed in 500 µl of buffer III and centrifuged at 2,000 g
for 2 min at 4 °C, to save the supernatant as the nucleolar
fraction34.
Immunoprecipitation
Recombinant protein G-agarose beads (10 μl per sam-
ple; Invitrogen, Carlsbab, CA, USA) were equilibrated by
gently agitation in lysis buffer (50mM Tris-HCl pH 8,
150mM NaCl, 1% Triton X-100, 2 mM Na3VO4, 25 mM
NaF, 10 mM Na2MoO4, 1 mM PMSF, and 1× complete
protease inhibitor mixture). We quantiﬁed 500 ug of
protein and the lysates were pre-cleared with equilibrated
beads for 2 h at 4 °C, the beads were removed by cen-
trifugation at 3,500 rpm for 5 min and the pre-cleared
extracts incubated overnight at 4 °C with the appropriate
antibody. Incubations with an irrelevant IgG antibody
were carried out in parallel. Thereafter, equilibrated
protein G-agarose beads blocked previously with 4% BSA
were added to the lysates and incubated overnight at 4 °C.
Immune complexes were collected by centrifugation at
3,500 rpm for 5 min, washed twice for 10min with 500 µl
of washing buffer (50 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA, 1% Tritón X-100, 1X complete protease inhibitor,
1 mM PMSF). Bound proteins were eluted from beads by
boiling in sample buffer (50 mM Tris-HCl pH 6.8, 2%
(w/v) SDS, 10% (v/v) glycerol, 0.1% (v/v) 2-mercap-
toethanol, 0.001% bromophenol blue), prior to being
subjected to western blot analysis. C2C12 cell lysates
expressing GFP-tagged proteins were subjected to IP
using the GFP-Trap® system (Chromotek, Germany),
according to the manufacturer’s instructions.
Quantitative reverse PCR (RT-qPCR)
For analysis of rRNA transcripts, total RNA was
extracted using Direct-zol TM RNA Miniprep Kit (Zymo
Research, Irvine, CA, USA), according to the manufac-
turer's instructions. And further analyzed by qRT-PCR
with speciﬁc primers amplifying 45 S pre-rRNA (for-
ward, 5′-GTGTCCAAGTGTTCATGCCA; reverse, 5′-
CGATCTAAGAGTGAGCAACGAC), 18 S rRNA (for-
ward, 5′-TTCCGACCATAAACGATGCC; reverse, 5′-
GCTCCACCAACTAAGAACGG), 28 S rRNA (forward,
5′-GATGGTGAACTATGCTTGGG; reverse, 5′-GAA-
TAGGTTGAGATCGTTTCGG), and GAPDH mRNA
(forward, 5′-CTTGGGCTACACTGAGGACC; reverse,
5′-CTGTTGCTGTAGCCGTATTC). For analysis of
DAG1 mRNA expression, the following primers were
used: forward, 5′-GAGATCATCAAGGTGTCTGCA
and reverse, 5′-GTGGCTCATTGTGGTCTTCAG. RT-
qPCR reactions were carried out in the StepOneplus
System (Life technologies), using KAPA SYBR® FAST
One-Step qRT-PCR Master Mix (2 × ) Kit, and further
analyzed with the StepOne Software v2.3. The data were
analyzed by comparative method 2−ΔΔCT.
RNA pol I reporter assays
C2C12 cells stably expressing GFP-ICD-βDG or GFP
alone were co-transfected with both the Renilla Luciferase
vector (transcribed by RNA polymerase II) as a control to
normalize for differences in transfection efﬁciency and
with the ﬁreﬂy luciferase RNA polymerase I reporter
vector (pMrTsp-9-T10). The two vectors were kindly
donated by Gernot Längst Lab., Regensburg University,
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Germany. After 48 h, the luciferase activity was measured
using Dual Luciferase Assay kit (Promega). The ﬁreﬂy
luciferase counts of the RNA polymerase I reporter were
divided by the Renilla luciferase counts and compared to
GFP control transfections.
Cell proliferation assays
C2C12 cells stably expressing GFP-ICD-βDG or GFP
alone were harvested and plated in triplicate onto 12 wells
microplates at 1 × 103 cells/mL conﬂuence. Proliferation
was measured for 13 days using the MTT (3-(4,5-dime-
thylthiazole)− 2–5-diphenyl tetrazolium bromide) com-
mercial kit (Sigma-Aldrich), following the manufacturer’s
instructions.
Chromatin immunoprecipitation assays
C2C12 cells were incubated with 1% formaldehyde in
PBS for 10 min at room temperature. Cross-link reaction
was stopped by adding glycine to a ﬁnal concentration of
125 mM. Cells were washed and harvested with cold
PBS. After centrifugation at 1500 g, the pellet was
resuspended in sonication buffer (50 mM Hepes pH 7.9,
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
sodium deoxycholate, 0.1% SDS and protease inhibitors).
Soluble and sheared chromatin were obtained by
applying ﬁve cycles of sonication on ice at 10% of
amplitude for 20 s (Q55 sonicator, Qsonica) and recov-
ered by centrifugation. Soluble chromatin was pre-
clariﬁed by mixing with 50 µl of recombinant protein
G-agarose beads (rPGA Invitrogen) and incubated with
shaking for 1 h at 4 °C. The mix was centrifuged at
3,000 × g for 1 min to remove rPGA. Twenty ﬁve
micrograms of pre-clariﬁed chromatin diluted 1:10 in
sonication buffer were mixed with 7.8 µg of mouse
puriﬁed serum anti-β-dystroglycan or 7.8 µg of mouse
IgG (irrelevant control). Finally 25 µl of rPGA were
added to each sample and incubate with shaking over-
night at 4 °C. Immunoprecipitated DNA-protein com-
plexes were extensively and sequentially washed with
sonication buffer, wash buffer A (50 mM Hepes pH 7.9,
500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
sodium deoxycholate, 0.1% SDS), wash buffer B (20 mM
Tris-Cl pH 8, 1 mM EDTA, 250 mM LiCl, 0.5% NP40,
0.5% deoxycholate), and TE buffer. Finally, the pellet was
incubated with shaking for 10 min at 65 °C in elution
buffer (50 mM Tris-Cl pH 8, 1 mM EDTA, 1% SDS, 50
mM NaHCO3). Supernatant was recovered by cen-
trifugation and the cross-link reversion was carried out
by adding RNAase A and Proteinase K to each sample
and incubating with shaking for 4 h at 65 °C. DNA was
recovered by phenol–chloroform extraction and ethanol
precipitation. Twenty nanograms of DNA was used to
perform quantitative PCR (qPCR), using SYBR green and
rDNA-speciﬁc primers as previously reported35,36.
Ribosomal proﬁle analysis
Cells grown at 80–90% conﬂuency were harvested,
washed with PBS with 100 μg/mL cycloheximide and
centrifuged at 5,000 rpm for 5 min at 4 °C, prior to sus-
pension in 200 μl of lysis buffer containing 100 μg/mL
cycloheximide and 1× complete protease inhibitor mix-
ture. Thereafter cells were centrifuged for 10min at
10,000 rpm and the supernatant was layered on top of a
15–50% sucrose gradient to be centrifuged at 25,000 rpm
for 5:30 h at 4 °C in a Beckman SW28Ti rotor. All gra-
dients were scanned at 260 nm from the top with an ISCO
gradient collector. Collected fractions were precipitated
with ethanol and centrifuged at 15,000 rpm for 30min to
obtain ribosomal particles.
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